Home/Osel/Peter P. Lee, PhD
PP

Peter P. Lee, PhD

Founder and Executive Chairman

Osel

Osel Pipeline

DrugIndicationPhase
MO-03 (CBM588)Advanced/Metastatic Renal Cell Carcinoma (in combo with IO)Phase 3
LACTIN-VRecurrent Bacterial VaginosisPhase 2
MucoCept-HIVHIV Prevention in WomenPreclinical